A 2026 systematic review (Dermatologic Therapy/Wiley) and several small randomized trials show conflicting results: some trials report increased hair density (13-20%) over 12-24 weeks, while a separate triple-blind, placebo-controlled JAAD trial found botulinum toxin did NOT improve hair regrowth and that terminal hair density actually decreased in the treated areas.
- Lab
- Phase 1
- Phase 2
- Phase 3
- Approved
In use (off-label)
How it works
Botulinum toxin injected into the scalp, hypothesized to relax scalp muscle tension (improving blood flow/oxygenation to follicles) and to have direct anti-inflammatory/anti-apoptotic effects on dermal papilla cells.
Results so far
Evidence is genuinely mixed: some studies report +13-20% hair density gains and improved follicle diameter with no major adverse effects; a triple-blind RCT published in JAAD found no benefit and a decrease in terminal hair density. No consensus efficacy figure exists.
What's next
Not on a path to a formal drug-style approval since it uses existing approved toxin products off-label for a cosmetic/dermatologic procedure; further trials are ongoing (e.g., a trial comparing botulinum toxin A vs nanofat is slated to start December 2026).
In India
Not specifically assessed; botulinum toxin is already widely available in India for its approved cosmetic/medical indications, so off-label scalp use for hair loss is plausible but was not verified in this research pass.
Sources
- Journal paper ↗ (accessed 2026-10-17)
- Journal paper ↗ (accessed 2026-10-17)
- Journal paper ↗ (accessed 2026-10-17)
- Trial registry ↗ (accessed 2026-10-17)
What to do today: treatments in development aren't a reason to wait. Ask a dermatologist about the options that work now, such as minoxidil and, for men, finasteride.
Discussion
Share your experience or ask a question. New members' posts are reviewed before they appear.